Medical Care
Global Sleep Disorder Therapeutics Market Research Report 2025
- Sep 09, 25
- ID: 494821
- Pages: 79
- Figures: 74
- Views: 7
This report aims to provide a comprehensive presentation of the global market for Sleep Disorder Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sleep Disorder Therapeutics.
The Sleep Disorder Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Sleep Disorder Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sleep Disorder Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
Sunovion Pharmaceuticals
Takeda Pharmaceutical
Somaxon Pharmaceuticals
Vanda Pharmaceuticals
Eli Lilly
GSK
Neurim Pharmaceuticals
Segment by Type
Insomnia
Excessive Sleep
Disturbed Sleep
Segment by Application
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Sleep Disorder Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Sleep Disorder Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Sleep Disorder Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sleep Disorder Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
Sunovion Pharmaceuticals
Takeda Pharmaceutical
Somaxon Pharmaceuticals
Vanda Pharmaceuticals
Eli Lilly
GSK
Neurim Pharmaceuticals
Segment by Type
Insomnia
Excessive Sleep
Disturbed Sleep
Segment by Application
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Sleep Disorder Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sleep Disorder Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Insomnia
1.2.3 Excessive Sleep
1.2.4 Disturbed Sleep
1.3 Market by Application
1.3.1 Global Sleep Disorder Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital Pharmacies
1.3.3 Online Pharmacies
1.3.4 Retail Pharmacies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Sleep Disorder Therapeutics Market Perspective (2020-2031)
2.2 Global Sleep Disorder Therapeutics Growth Trends by Region
2.2.1 Global Sleep Disorder Therapeutics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Sleep Disorder Therapeutics Historic Market Size by Region (2020-2025)
2.2.3 Sleep Disorder Therapeutics Forecasted Market Size by Region (2026-2031)
2.3 Sleep Disorder Therapeutics Market Dynamics
2.3.1 Sleep Disorder Therapeutics Industry Trends
2.3.2 Sleep Disorder Therapeutics Market Drivers
2.3.3 Sleep Disorder Therapeutics Market Challenges
2.3.4 Sleep Disorder Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Sleep Disorder Therapeutics Players by Revenue
3.1.1 Global Top Sleep Disorder Therapeutics Players by Revenue (2020-2025)
3.1.2 Global Sleep Disorder Therapeutics Revenue Market Share by Players (2020-2025)
3.2 Global Sleep Disorder Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Sleep Disorder Therapeutics Revenue
3.4 Global Sleep Disorder Therapeutics Market Concentration Ratio
3.4.1 Global Sleep Disorder Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sleep Disorder Therapeutics Revenue in 2024
3.5 Global Key Players of Sleep Disorder Therapeutics Head office and Area Served
3.6 Global Key Players of Sleep Disorder Therapeutics, Product and Application
3.7 Global Key Players of Sleep Disorder Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Sleep Disorder Therapeutics Breakdown Data by Type
4.1 Global Sleep Disorder Therapeutics Historic Market Size by Type (2020-2025)
4.2 Global Sleep Disorder Therapeutics Forecasted Market Size by Type (2026-2031)
5 Sleep Disorder Therapeutics Breakdown Data by Application
5.1 Global Sleep Disorder Therapeutics Historic Market Size by Application (2020-2025)
5.2 Global Sleep Disorder Therapeutics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Sleep Disorder Therapeutics Market Size (2020-2031)
6.2 North America Sleep Disorder Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Sleep Disorder Therapeutics Market Size by Country (2020-2025)
6.4 North America Sleep Disorder Therapeutics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Sleep Disorder Therapeutics Market Size (2020-2031)
7.2 Europe Sleep Disorder Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Sleep Disorder Therapeutics Market Size by Country (2020-2025)
7.4 Europe Sleep Disorder Therapeutics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Sleep Disorder Therapeutics Market Size (2020-2031)
8.2 Asia-Pacific Sleep Disorder Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Sleep Disorder Therapeutics Market Size by Region (2020-2025)
8.4 Asia-Pacific Sleep Disorder Therapeutics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Sleep Disorder Therapeutics Market Size (2020-2031)
9.2 Latin America Sleep Disorder Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Sleep Disorder Therapeutics Market Size by Country (2020-2025)
9.4 Latin America Sleep Disorder Therapeutics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Sleep Disorder Therapeutics Market Size (2020-2031)
10.2 Middle East & Africa Sleep Disorder Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Sleep Disorder Therapeutics Market Size by Country (2020-2025)
10.4 Middle East & Africa Sleep Disorder Therapeutics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Details
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Sleep Disorder Therapeutics Introduction
11.1.4 Sanofi Revenue in Sleep Disorder Therapeutics Business (2020-2025)
11.1.5 Sanofi Recent Development
11.2 Sunovion Pharmaceuticals
11.2.1 Sunovion Pharmaceuticals Company Details
11.2.2 Sunovion Pharmaceuticals Business Overview
11.2.3 Sunovion Pharmaceuticals Sleep Disorder Therapeutics Introduction
11.2.4 Sunovion Pharmaceuticals Revenue in Sleep Disorder Therapeutics Business (2020-2025)
11.2.5 Sunovion Pharmaceuticals Recent Development
11.3 Takeda Pharmaceutical
11.3.1 Takeda Pharmaceutical Company Details
11.3.2 Takeda Pharmaceutical Business Overview
11.3.3 Takeda Pharmaceutical Sleep Disorder Therapeutics Introduction
11.3.4 Takeda Pharmaceutical Revenue in Sleep Disorder Therapeutics Business (2020-2025)
11.3.5 Takeda Pharmaceutical Recent Development
11.4 Somaxon Pharmaceuticals
11.4.1 Somaxon Pharmaceuticals Company Details
11.4.2 Somaxon Pharmaceuticals Business Overview
11.4.3 Somaxon Pharmaceuticals Sleep Disorder Therapeutics Introduction
11.4.4 Somaxon Pharmaceuticals Revenue in Sleep Disorder Therapeutics Business (2020-2025)
11.4.5 Somaxon Pharmaceuticals Recent Development
11.5 Vanda Pharmaceuticals
11.5.1 Vanda Pharmaceuticals Company Details
11.5.2 Vanda Pharmaceuticals Business Overview
11.5.3 Vanda Pharmaceuticals Sleep Disorder Therapeutics Introduction
11.5.4 Vanda Pharmaceuticals Revenue in Sleep Disorder Therapeutics Business (2020-2025)
11.5.5 Vanda Pharmaceuticals Recent Development
11.6 Eli Lilly
11.6.1 Eli Lilly Company Details
11.6.2 Eli Lilly Business Overview
11.6.3 Eli Lilly Sleep Disorder Therapeutics Introduction
11.6.4 Eli Lilly Revenue in Sleep Disorder Therapeutics Business (2020-2025)
11.6.5 Eli Lilly Recent Development
11.7 GSK
11.7.1 GSK Company Details
11.7.2 GSK Business Overview
11.7.3 GSK Sleep Disorder Therapeutics Introduction
11.7.4 GSK Revenue in Sleep Disorder Therapeutics Business (2020-2025)
11.7.5 GSK Recent Development
11.8 Neurim Pharmaceuticals
11.8.1 Neurim Pharmaceuticals Company Details
11.8.2 Neurim Pharmaceuticals Business Overview
11.8.3 Neurim Pharmaceuticals Sleep Disorder Therapeutics Introduction
11.8.4 Neurim Pharmaceuticals Revenue in Sleep Disorder Therapeutics Business (2020-2025)
11.8.5 Neurim Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sleep Disorder Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Insomnia
1.2.3 Excessive Sleep
1.2.4 Disturbed Sleep
1.3 Market by Application
1.3.1 Global Sleep Disorder Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital Pharmacies
1.3.3 Online Pharmacies
1.3.4 Retail Pharmacies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Sleep Disorder Therapeutics Market Perspective (2020-2031)
2.2 Global Sleep Disorder Therapeutics Growth Trends by Region
2.2.1 Global Sleep Disorder Therapeutics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Sleep Disorder Therapeutics Historic Market Size by Region (2020-2025)
2.2.3 Sleep Disorder Therapeutics Forecasted Market Size by Region (2026-2031)
2.3 Sleep Disorder Therapeutics Market Dynamics
2.3.1 Sleep Disorder Therapeutics Industry Trends
2.3.2 Sleep Disorder Therapeutics Market Drivers
2.3.3 Sleep Disorder Therapeutics Market Challenges
2.3.4 Sleep Disorder Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Sleep Disorder Therapeutics Players by Revenue
3.1.1 Global Top Sleep Disorder Therapeutics Players by Revenue (2020-2025)
3.1.2 Global Sleep Disorder Therapeutics Revenue Market Share by Players (2020-2025)
3.2 Global Sleep Disorder Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Sleep Disorder Therapeutics Revenue
3.4 Global Sleep Disorder Therapeutics Market Concentration Ratio
3.4.1 Global Sleep Disorder Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sleep Disorder Therapeutics Revenue in 2024
3.5 Global Key Players of Sleep Disorder Therapeutics Head office and Area Served
3.6 Global Key Players of Sleep Disorder Therapeutics, Product and Application
3.7 Global Key Players of Sleep Disorder Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Sleep Disorder Therapeutics Breakdown Data by Type
4.1 Global Sleep Disorder Therapeutics Historic Market Size by Type (2020-2025)
4.2 Global Sleep Disorder Therapeutics Forecasted Market Size by Type (2026-2031)
5 Sleep Disorder Therapeutics Breakdown Data by Application
5.1 Global Sleep Disorder Therapeutics Historic Market Size by Application (2020-2025)
5.2 Global Sleep Disorder Therapeutics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Sleep Disorder Therapeutics Market Size (2020-2031)
6.2 North America Sleep Disorder Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Sleep Disorder Therapeutics Market Size by Country (2020-2025)
6.4 North America Sleep Disorder Therapeutics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Sleep Disorder Therapeutics Market Size (2020-2031)
7.2 Europe Sleep Disorder Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Sleep Disorder Therapeutics Market Size by Country (2020-2025)
7.4 Europe Sleep Disorder Therapeutics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Sleep Disorder Therapeutics Market Size (2020-2031)
8.2 Asia-Pacific Sleep Disorder Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Sleep Disorder Therapeutics Market Size by Region (2020-2025)
8.4 Asia-Pacific Sleep Disorder Therapeutics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Sleep Disorder Therapeutics Market Size (2020-2031)
9.2 Latin America Sleep Disorder Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Sleep Disorder Therapeutics Market Size by Country (2020-2025)
9.4 Latin America Sleep Disorder Therapeutics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Sleep Disorder Therapeutics Market Size (2020-2031)
10.2 Middle East & Africa Sleep Disorder Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Sleep Disorder Therapeutics Market Size by Country (2020-2025)
10.4 Middle East & Africa Sleep Disorder Therapeutics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Details
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Sleep Disorder Therapeutics Introduction
11.1.4 Sanofi Revenue in Sleep Disorder Therapeutics Business (2020-2025)
11.1.5 Sanofi Recent Development
11.2 Sunovion Pharmaceuticals
11.2.1 Sunovion Pharmaceuticals Company Details
11.2.2 Sunovion Pharmaceuticals Business Overview
11.2.3 Sunovion Pharmaceuticals Sleep Disorder Therapeutics Introduction
11.2.4 Sunovion Pharmaceuticals Revenue in Sleep Disorder Therapeutics Business (2020-2025)
11.2.5 Sunovion Pharmaceuticals Recent Development
11.3 Takeda Pharmaceutical
11.3.1 Takeda Pharmaceutical Company Details
11.3.2 Takeda Pharmaceutical Business Overview
11.3.3 Takeda Pharmaceutical Sleep Disorder Therapeutics Introduction
11.3.4 Takeda Pharmaceutical Revenue in Sleep Disorder Therapeutics Business (2020-2025)
11.3.5 Takeda Pharmaceutical Recent Development
11.4 Somaxon Pharmaceuticals
11.4.1 Somaxon Pharmaceuticals Company Details
11.4.2 Somaxon Pharmaceuticals Business Overview
11.4.3 Somaxon Pharmaceuticals Sleep Disorder Therapeutics Introduction
11.4.4 Somaxon Pharmaceuticals Revenue in Sleep Disorder Therapeutics Business (2020-2025)
11.4.5 Somaxon Pharmaceuticals Recent Development
11.5 Vanda Pharmaceuticals
11.5.1 Vanda Pharmaceuticals Company Details
11.5.2 Vanda Pharmaceuticals Business Overview
11.5.3 Vanda Pharmaceuticals Sleep Disorder Therapeutics Introduction
11.5.4 Vanda Pharmaceuticals Revenue in Sleep Disorder Therapeutics Business (2020-2025)
11.5.5 Vanda Pharmaceuticals Recent Development
11.6 Eli Lilly
11.6.1 Eli Lilly Company Details
11.6.2 Eli Lilly Business Overview
11.6.3 Eli Lilly Sleep Disorder Therapeutics Introduction
11.6.4 Eli Lilly Revenue in Sleep Disorder Therapeutics Business (2020-2025)
11.6.5 Eli Lilly Recent Development
11.7 GSK
11.7.1 GSK Company Details
11.7.2 GSK Business Overview
11.7.3 GSK Sleep Disorder Therapeutics Introduction
11.7.4 GSK Revenue in Sleep Disorder Therapeutics Business (2020-2025)
11.7.5 GSK Recent Development
11.8 Neurim Pharmaceuticals
11.8.1 Neurim Pharmaceuticals Company Details
11.8.2 Neurim Pharmaceuticals Business Overview
11.8.3 Neurim Pharmaceuticals Sleep Disorder Therapeutics Introduction
11.8.4 Neurim Pharmaceuticals Revenue in Sleep Disorder Therapeutics Business (2020-2025)
11.8.5 Neurim Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Sleep Disorder Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Insomnia
Table 3. Key Players of Excessive Sleep
Table 4. Key Players of Disturbed Sleep
Table 5. Global Sleep Disorder Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Sleep Disorder Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Sleep Disorder Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Sleep Disorder Therapeutics Market Share by Region (2020-2025)
Table 9. Global Sleep Disorder Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Sleep Disorder Therapeutics Market Share by Region (2026-2031)
Table 11. Sleep Disorder Therapeutics Market Trends
Table 12. Sleep Disorder Therapeutics Market Drivers
Table 13. Sleep Disorder Therapeutics Market Challenges
Table 14. Sleep Disorder Therapeutics Market Restraints
Table 15. Global Sleep Disorder Therapeutics Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Sleep Disorder Therapeutics Market Share by Players (2020-2025)
Table 17. Global Top Sleep Disorder Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sleep Disorder Therapeutics as of 2024)
Table 18. Ranking of Global Top Sleep Disorder Therapeutics Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Sleep Disorder Therapeutics Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Sleep Disorder Therapeutics, Headquarters and Area Served
Table 21. Global Key Players of Sleep Disorder Therapeutics, Product and Application
Table 22. Global Key Players of Sleep Disorder Therapeutics, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Sleep Disorder Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Sleep Disorder Therapeutics Revenue Market Share by Type (2020-2025)
Table 26. Global Sleep Disorder Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Sleep Disorder Therapeutics Revenue Market Share by Type (2026-2031)
Table 28. Global Sleep Disorder Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Sleep Disorder Therapeutics Revenue Market Share by Application (2020-2025)
Table 30. Global Sleep Disorder Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Sleep Disorder Therapeutics Revenue Market Share by Application (2026-2031)
Table 32. North America Sleep Disorder Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Sleep Disorder Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Sleep Disorder Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Sleep Disorder Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Sleep Disorder Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Sleep Disorder Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Sleep Disorder Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Sleep Disorder Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Sleep Disorder Therapeutics Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Sleep Disorder Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Sleep Disorder Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Sleep Disorder Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Sleep Disorder Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Sleep Disorder Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Sleep Disorder Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 47. Sanofi Company Details
Table 48. Sanofi Business Overview
Table 49. Sanofi Sleep Disorder Therapeutics Product
Table 50. Sanofi Revenue in Sleep Disorder Therapeutics Business (2020-2025) & (US$ Million)
Table 51. Sanofi Recent Development
Table 52. Sunovion Pharmaceuticals Company Details
Table 53. Sunovion Pharmaceuticals Business Overview
Table 54. Sunovion Pharmaceuticals Sleep Disorder Therapeutics Product
Table 55. Sunovion Pharmaceuticals Revenue in Sleep Disorder Therapeutics Business (2020-2025) & (US$ Million)
Table 56. Sunovion Pharmaceuticals Recent Development
Table 57. Takeda Pharmaceutical Company Details
Table 58. Takeda Pharmaceutical Business Overview
Table 59. Takeda Pharmaceutical Sleep Disorder Therapeutics Product
Table 60. Takeda Pharmaceutical Revenue in Sleep Disorder Therapeutics Business (2020-2025) & (US$ Million)
Table 61. Takeda Pharmaceutical Recent Development
Table 62. Somaxon Pharmaceuticals Company Details
Table 63. Somaxon Pharmaceuticals Business Overview
Table 64. Somaxon Pharmaceuticals Sleep Disorder Therapeutics Product
Table 65. Somaxon Pharmaceuticals Revenue in Sleep Disorder Therapeutics Business (2020-2025) & (US$ Million)
Table 66. Somaxon Pharmaceuticals Recent Development
Table 67. Vanda Pharmaceuticals Company Details
Table 68. Vanda Pharmaceuticals Business Overview
Table 69. Vanda Pharmaceuticals Sleep Disorder Therapeutics Product
Table 70. Vanda Pharmaceuticals Revenue in Sleep Disorder Therapeutics Business (2020-2025) & (US$ Million)
Table 71. Vanda Pharmaceuticals Recent Development
Table 72. Eli Lilly Company Details
Table 73. Eli Lilly Business Overview
Table 74. Eli Lilly Sleep Disorder Therapeutics Product
Table 75. Eli Lilly Revenue in Sleep Disorder Therapeutics Business (2020-2025) & (US$ Million)
Table 76. Eli Lilly Recent Development
Table 77. GSK Company Details
Table 78. GSK Business Overview
Table 79. GSK Sleep Disorder Therapeutics Product
Table 80. GSK Revenue in Sleep Disorder Therapeutics Business (2020-2025) & (US$ Million)
Table 81. GSK Recent Development
Table 82. Neurim Pharmaceuticals Company Details
Table 83. Neurim Pharmaceuticals Business Overview
Table 84. Neurim Pharmaceuticals Sleep Disorder Therapeutics Product
Table 85. Neurim Pharmaceuticals Revenue in Sleep Disorder Therapeutics Business (2020-2025) & (US$ Million)
Table 86. Neurim Pharmaceuticals Recent Development
Table 87. Research Programs/Design for This Report
Table 88. Key Data Information from Secondary Sources
Table 89. Key Data Information from Primary Sources
Table 90. Authors List of This Report
List of Figures
Figure 1. Sleep Disorder Therapeutics Picture
Figure 2. Global Sleep Disorder Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Sleep Disorder Therapeutics Market Share by Type: 2024 VS 2031
Figure 4. Insomnia Features
Figure 5. Excessive Sleep Features
Figure 6. Disturbed Sleep Features
Figure 7. Global Sleep Disorder Therapeutics Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Sleep Disorder Therapeutics Market Share by Application: 2024 VS 2031
Figure 9. Hospital Pharmacies Case Studies
Figure 10. Online Pharmacies Case Studies
Figure 11. Retail Pharmacies Case Studies
Figure 12. Sleep Disorder Therapeutics Report Years Considered
Figure 13. Global Sleep Disorder Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Sleep Disorder Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Sleep Disorder Therapeutics Market Share by Region: 2024 VS 2031
Figure 16. Global Sleep Disorder Therapeutics Market Share by Players in 2024
Figure 17. Global Top Sleep Disorder Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sleep Disorder Therapeutics as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Sleep Disorder Therapeutics Revenue in 2024
Figure 19. North America Sleep Disorder Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Sleep Disorder Therapeutics Market Share by Country (2020-2031)
Figure 21. United States Sleep Disorder Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Sleep Disorder Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Sleep Disorder Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Sleep Disorder Therapeutics Market Share by Country (2020-2031)
Figure 25. Germany Sleep Disorder Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Sleep Disorder Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Sleep Disorder Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Sleep Disorder Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Sleep Disorder Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Sleep Disorder Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Sleep Disorder Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Sleep Disorder Therapeutics Market Share by Region (2020-2031)
Figure 33. China Sleep Disorder Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Sleep Disorder Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Sleep Disorder Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Sleep Disorder Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Sleep Disorder Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Sleep Disorder Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Sleep Disorder Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Sleep Disorder Therapeutics Market Share by Country (2020-2031)
Figure 41. Mexico Sleep Disorder Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Sleep Disorder Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Sleep Disorder Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Sleep Disorder Therapeutics Market Share by Country (2020-2031)
Figure 45. Turkey Sleep Disorder Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Sleep Disorder Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Sleep Disorder Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Sanofi Revenue Growth Rate in Sleep Disorder Therapeutics Business (2020-2025)
Figure 49. Sunovion Pharmaceuticals Revenue Growth Rate in Sleep Disorder Therapeutics Business (2020-2025)
Figure 50. Takeda Pharmaceutical Revenue Growth Rate in Sleep Disorder Therapeutics Business (2020-2025)
Figure 51. Somaxon Pharmaceuticals Revenue Growth Rate in Sleep Disorder Therapeutics Business (2020-2025)
Figure 52. Vanda Pharmaceuticals Revenue Growth Rate in Sleep Disorder Therapeutics Business (2020-2025)
Figure 53. Eli Lilly Revenue Growth Rate in Sleep Disorder Therapeutics Business (2020-2025)
Figure 54. GSK Revenue Growth Rate in Sleep Disorder Therapeutics Business (2020-2025)
Figure 55. Neurim Pharmaceuticals Revenue Growth Rate in Sleep Disorder Therapeutics Business (2020-2025)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Table 1. Global Sleep Disorder Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Insomnia
Table 3. Key Players of Excessive Sleep
Table 4. Key Players of Disturbed Sleep
Table 5. Global Sleep Disorder Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Sleep Disorder Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Sleep Disorder Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Sleep Disorder Therapeutics Market Share by Region (2020-2025)
Table 9. Global Sleep Disorder Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Sleep Disorder Therapeutics Market Share by Region (2026-2031)
Table 11. Sleep Disorder Therapeutics Market Trends
Table 12. Sleep Disorder Therapeutics Market Drivers
Table 13. Sleep Disorder Therapeutics Market Challenges
Table 14. Sleep Disorder Therapeutics Market Restraints
Table 15. Global Sleep Disorder Therapeutics Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Sleep Disorder Therapeutics Market Share by Players (2020-2025)
Table 17. Global Top Sleep Disorder Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sleep Disorder Therapeutics as of 2024)
Table 18. Ranking of Global Top Sleep Disorder Therapeutics Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Sleep Disorder Therapeutics Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Sleep Disorder Therapeutics, Headquarters and Area Served
Table 21. Global Key Players of Sleep Disorder Therapeutics, Product and Application
Table 22. Global Key Players of Sleep Disorder Therapeutics, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Sleep Disorder Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Sleep Disorder Therapeutics Revenue Market Share by Type (2020-2025)
Table 26. Global Sleep Disorder Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Sleep Disorder Therapeutics Revenue Market Share by Type (2026-2031)
Table 28. Global Sleep Disorder Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Sleep Disorder Therapeutics Revenue Market Share by Application (2020-2025)
Table 30. Global Sleep Disorder Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Sleep Disorder Therapeutics Revenue Market Share by Application (2026-2031)
Table 32. North America Sleep Disorder Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Sleep Disorder Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Sleep Disorder Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Sleep Disorder Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Sleep Disorder Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Sleep Disorder Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Sleep Disorder Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Sleep Disorder Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Sleep Disorder Therapeutics Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Sleep Disorder Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Sleep Disorder Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Sleep Disorder Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Sleep Disorder Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Sleep Disorder Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Sleep Disorder Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 47. Sanofi Company Details
Table 48. Sanofi Business Overview
Table 49. Sanofi Sleep Disorder Therapeutics Product
Table 50. Sanofi Revenue in Sleep Disorder Therapeutics Business (2020-2025) & (US$ Million)
Table 51. Sanofi Recent Development
Table 52. Sunovion Pharmaceuticals Company Details
Table 53. Sunovion Pharmaceuticals Business Overview
Table 54. Sunovion Pharmaceuticals Sleep Disorder Therapeutics Product
Table 55. Sunovion Pharmaceuticals Revenue in Sleep Disorder Therapeutics Business (2020-2025) & (US$ Million)
Table 56. Sunovion Pharmaceuticals Recent Development
Table 57. Takeda Pharmaceutical Company Details
Table 58. Takeda Pharmaceutical Business Overview
Table 59. Takeda Pharmaceutical Sleep Disorder Therapeutics Product
Table 60. Takeda Pharmaceutical Revenue in Sleep Disorder Therapeutics Business (2020-2025) & (US$ Million)
Table 61. Takeda Pharmaceutical Recent Development
Table 62. Somaxon Pharmaceuticals Company Details
Table 63. Somaxon Pharmaceuticals Business Overview
Table 64. Somaxon Pharmaceuticals Sleep Disorder Therapeutics Product
Table 65. Somaxon Pharmaceuticals Revenue in Sleep Disorder Therapeutics Business (2020-2025) & (US$ Million)
Table 66. Somaxon Pharmaceuticals Recent Development
Table 67. Vanda Pharmaceuticals Company Details
Table 68. Vanda Pharmaceuticals Business Overview
Table 69. Vanda Pharmaceuticals Sleep Disorder Therapeutics Product
Table 70. Vanda Pharmaceuticals Revenue in Sleep Disorder Therapeutics Business (2020-2025) & (US$ Million)
Table 71. Vanda Pharmaceuticals Recent Development
Table 72. Eli Lilly Company Details
Table 73. Eli Lilly Business Overview
Table 74. Eli Lilly Sleep Disorder Therapeutics Product
Table 75. Eli Lilly Revenue in Sleep Disorder Therapeutics Business (2020-2025) & (US$ Million)
Table 76. Eli Lilly Recent Development
Table 77. GSK Company Details
Table 78. GSK Business Overview
Table 79. GSK Sleep Disorder Therapeutics Product
Table 80. GSK Revenue in Sleep Disorder Therapeutics Business (2020-2025) & (US$ Million)
Table 81. GSK Recent Development
Table 82. Neurim Pharmaceuticals Company Details
Table 83. Neurim Pharmaceuticals Business Overview
Table 84. Neurim Pharmaceuticals Sleep Disorder Therapeutics Product
Table 85. Neurim Pharmaceuticals Revenue in Sleep Disorder Therapeutics Business (2020-2025) & (US$ Million)
Table 86. Neurim Pharmaceuticals Recent Development
Table 87. Research Programs/Design for This Report
Table 88. Key Data Information from Secondary Sources
Table 89. Key Data Information from Primary Sources
Table 90. Authors List of This Report
List of Figures
Figure 1. Sleep Disorder Therapeutics Picture
Figure 2. Global Sleep Disorder Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Sleep Disorder Therapeutics Market Share by Type: 2024 VS 2031
Figure 4. Insomnia Features
Figure 5. Excessive Sleep Features
Figure 6. Disturbed Sleep Features
Figure 7. Global Sleep Disorder Therapeutics Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Sleep Disorder Therapeutics Market Share by Application: 2024 VS 2031
Figure 9. Hospital Pharmacies Case Studies
Figure 10. Online Pharmacies Case Studies
Figure 11. Retail Pharmacies Case Studies
Figure 12. Sleep Disorder Therapeutics Report Years Considered
Figure 13. Global Sleep Disorder Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Sleep Disorder Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Sleep Disorder Therapeutics Market Share by Region: 2024 VS 2031
Figure 16. Global Sleep Disorder Therapeutics Market Share by Players in 2024
Figure 17. Global Top Sleep Disorder Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sleep Disorder Therapeutics as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Sleep Disorder Therapeutics Revenue in 2024
Figure 19. North America Sleep Disorder Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Sleep Disorder Therapeutics Market Share by Country (2020-2031)
Figure 21. United States Sleep Disorder Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Sleep Disorder Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Sleep Disorder Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Sleep Disorder Therapeutics Market Share by Country (2020-2031)
Figure 25. Germany Sleep Disorder Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Sleep Disorder Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Sleep Disorder Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Sleep Disorder Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Sleep Disorder Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Sleep Disorder Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Sleep Disorder Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Sleep Disorder Therapeutics Market Share by Region (2020-2031)
Figure 33. China Sleep Disorder Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Sleep Disorder Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Sleep Disorder Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Sleep Disorder Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Sleep Disorder Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Sleep Disorder Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Sleep Disorder Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Sleep Disorder Therapeutics Market Share by Country (2020-2031)
Figure 41. Mexico Sleep Disorder Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Sleep Disorder Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Sleep Disorder Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Sleep Disorder Therapeutics Market Share by Country (2020-2031)
Figure 45. Turkey Sleep Disorder Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Sleep Disorder Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Sleep Disorder Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Sanofi Revenue Growth Rate in Sleep Disorder Therapeutics Business (2020-2025)
Figure 49. Sunovion Pharmaceuticals Revenue Growth Rate in Sleep Disorder Therapeutics Business (2020-2025)
Figure 50. Takeda Pharmaceutical Revenue Growth Rate in Sleep Disorder Therapeutics Business (2020-2025)
Figure 51. Somaxon Pharmaceuticals Revenue Growth Rate in Sleep Disorder Therapeutics Business (2020-2025)
Figure 52. Vanda Pharmaceuticals Revenue Growth Rate in Sleep Disorder Therapeutics Business (2020-2025)
Figure 53. Eli Lilly Revenue Growth Rate in Sleep Disorder Therapeutics Business (2020-2025)
Figure 54. GSK Revenue Growth Rate in Sleep Disorder Therapeutics Business (2020-2025)
Figure 55. Neurim Pharmaceuticals Revenue Growth Rate in Sleep Disorder Therapeutics Business (2020-2025)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Spatial Metabolomics Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 04, 25
Global Pharmaceutical Process Analytical Technology (PAT) Software Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 04, 25
Global HASE Rheology Modifiers Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 04, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232